Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf is a New York Plaintiff's personal injury law firm specializing in automobile accidents, construction accidents, medical malpractice, products liability, police misconduct and all types of New York personal injury litigation.
Published on:

By

Since 2008 construction workers at Bekset Mansonry (NJ) have been exposed to scaffolding hazards that could have lead to serious injuries and fatal accidents.

Cross%20braces%20prohibited.pngThe construction company was cited for 3 repeat violations (lack of fall protection, use of scaffold cross braces to access the scaffold’s walking and working area and missing toe boards) and 5 serious violations including hazardous scaffolding and lack of proper training on scaffold and portable extension ladder set up.

65 percent of the construction industry, work on scaffolds frequently. Protecting these workers from scaffold-related accidents would prevent 4,500 construction accident injuries and 50 deaths every year, at a saving for American employers of $90 million dollars in workdays not lost, according to OSHA.

Continue reading →
Published on:

By

BR.jpgOur Partner, Ben Rubinowitz will chair the New York State Trial Lawyers Association Seminar Successful Examination of Expert Witnesses 2013 to be held on April 23, 2013, 6:00 PM – 9:00 PM. The Seminar will be held at NYSTLA, 132 Nassau Street, 2nd Floor, New York, NY 10038. Attendees will receive 3 CLE Credits in Skills. The Seminar will cover:

– Direct and Cross of an Orthopedist, Direct of a Radiologist, Cross Examination of the “Independent Medical Examiner”, Direct and Cross of an expert in a Medical Malpractice case,the effective use of Exhibits, How to deal with problem areas including the pre-existing injury, the professional testifier, the non-responsive expert witness, use of authoritative texts and the hypothetical question.

For more information and to register click here.

Published on:

By

Our Partner Richard Steigman was the chair for the annual New York State Trial Lawyers Association Seminar CPLR 2013 Update. Hon. Ariel E. Belen, Justice, Appellate Division, Second Department (retired) Mediator,JAMS was also on the faculty. This seminar provided an in depth review of new developments, including practice tips and pitfall warnings that are invaluable for the civil litigator.

In the video below you will find an extract from the seminar. The complete course can be found for CLE credit at the online store of the New York State Trial Lawyers Association

Published on:

By

In 2009, 21% of elderly enrollees in Medicare Advanatge received at least one high risk medication and 4.8% received at least two according to a redent study published in the Journal of Internal Medicine by Danya Qato, a pharmacist and doctoral candidate in health services research at Brown and Dr. Amal Trivedi, assistant professor of health services, policy and practice at Brown and a hospitalist at the Providence VA Medical Center

The study shows that the risk is much higher among residents of the South, women and people living in poor areas. The map below shows the percentage of seniors who received one or more high-risk medications in 2009 by region
high%20risk%20prescription%20pill%20use%20by%20region%20large.png
Credit: Danya Qato/Brown University

Published on:

By

In this New York motorcycle accident case, our partner, Christopher L. Sallay, won summary judgment on behalf of the plaintiff. Justice Arlene P. Bluth held that plaintiff demonstrated their prima facie entitlement to judgment as a matter of law by establishing that the defendant violated New York Vehicle and Traffic Law Section 1141 when she made a left turn directly into the plaintiff’s path.

To read the full decision click here.

Published on:

By

Use of cell phones or other electronic devices while driving is dangerous and can cause fatal car accidents. Most drivers know this but they still use their cell phones or other mobile devices to text, look at travel directions, check their emails, consult their calendar appointments, surf the web or play video games.

According to the latest National Occupant Protection Use Survey (NOPUS) “Driver Electronic Device Use in 2011“, texting or manipulating an hand held device while driving significantly increased from 2010 to 2011.

The trend is particularly alarming among young drivers and women.

Continue reading →
Published on:

By

Colon cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death in the US. Although it is largely preventable through colonoscopy, screening remains underutilized.

A recent study by Hanna M. Zafar, MD, MHS at the Perelman School of Medicine at the University of Pennsylvania shows that despite reimbursement limitations, computed tomography colonography (CTC) or virtual colonoscopy may expand screening to more patients. The study “Predictors of CT Colonography Utilization Among Asymptomatic Medicare Beneficiaries” can be found online in the Journal of General Internal Medicine.

Published on:

By

For patients with end-stage liver disease, transplantation is the only treatment option to extend life, however because of the short supply of donated liver, candidate selection for liver transplantation presents challenging ethical issues that require balancing the principles of justice and utility.

A recent anonymous study among U.S. transplant providers shows that chances to get a transplant are limited for candidates with history of alcohol and marijuana abuse, HIV status, obesity, psychiatric diagnoses, advanced age or for those who are incarcerated.

“National survey of provider opinions on controversial characteristics of liver transplant candidates”, by Katharine Secunda, Elisa J. Gordon, Min W. Sohn, Laura A. Shinkunas, Lauris C. Kaldjian, Michael D. VoigtJosh Levitsky is published in the April issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Published on:

By

A new study published in CANCER, a peer-reviewed journal of the American Cancer Society, shows that Amioradone, marketed since 1985 and used for arrhythmia or irregular heartbeats may increase cancer especially for patient using large doses.

Published on:

By

In “Beyond Mammography: New Frontiers in Breast Cancer Screening”, American Journal of Medicine, Jennifer S. Drukteinis, MD (Moffitt Cancer Center), Blaise P. Mooney, MD, Chris I. Flowers, MBBS, Robert A. Gatenby, MD, look at a personalized approach to breast cancer screening using new technologies such as low-dose mammography, contrast-enhanced mammography, tomosynthesis, automated whole breast ultrasound, molecular imaging, and magnetic resonance imaging. The study says this approach may lead to a better detection of breast cancer both in the general population and in high-risk groups, such as women with dense breasts.

  1. Pages:
  3. 1
  4. ...
  5. 356
  6. 357
  7. 358
  8. 359
  9. 360
  10. 361
  11. 362
  12. ...
  13. 387
Badges
Super Lawyers Best Lawyers Martindale-Hubbell
SEE NEW JERSEY DISCLAIMER PAGE- AWARD METHODOLOGY